Optas LLC Boosts Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Optas LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.3% during the fourth quarter, HoldingsChannel reports. The firm owned 2,937 shares of the company’s stock after purchasing an additional 298 shares during the quarter. Optas LLC’s holdings in GE HealthCare Technologies were worth $230,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. LGT Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 251 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in GE HealthCare Technologies during the third quarter valued at about $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the third quarter worth about $26,000. Darwin Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies in the third quarter worth about $31,000. Finally, Continuum Advisory LLC raised its position in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 0.7 %

Shares of NASDAQ GEHC opened at $86.93 on Wednesday. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The business has a 50-day moving average of $83.06 and a 200-day moving average of $85.13. The firm has a market capitalization of $39.72 billion, a price-to-earnings ratio of 23.88, a PEG ratio of 2.92 and a beta of 1.14. GE HealthCare Technologies Inc. has a 12 month low of $72.61 and a 12 month high of $94.55.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Analyst Upgrades and Downgrades

Several research firms recently commented on GEHC. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.